DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma
暂无分享,去创建一个
[1] C. Ricketts,et al. Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma , 2012, Epigenetics.
[2] M. Esteller,et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.
[3] R. Müller,et al. NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway , 2011, The Journal of cell biology.
[4] R. Lothe,et al. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis , 2011, Oncogene.
[5] N Clarke,et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma , 2011, Oncogene.
[6] P. A. Futreal,et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.
[7] E. Maher. Genetics of Familial Renal Cancers , 2010, Nephron Experimental Nephrology.
[8] E. Maher,et al. Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics , 2010, Genome Medicine.
[9] P. Karakiewicz,et al. Treatment of metastatic renal cell carcinoma , 2010, Nature Reviews Urology.
[10] Ximing J. Yang,et al. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma , 2010, BMC Cancer.
[11] W. Linehan,et al. The genetic basis of kidney cancer: a metabolic disease , 2010, Nature Reviews Urology.
[12] Gurpreet W. Tang,et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.
[13] Bin Tean Teh,et al. MicroRNA profiling of human kidney cancer subtypes. , 2009, International journal of oncology.
[14] J. Ragoussis,et al. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma , 2009, Molecular Cancer.
[15] Börje Ljungberg,et al. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas , 2009, BMC Cancer.
[16] Bin Tean Teh,et al. Somatic mutations of the histone H3K27 demethylase, UTX, in human cancer , 2009, Nature Genetics.
[17] A. Feinberg,et al. Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.
[18] Pan Du,et al. lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..
[19] B. Teh,et al. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. , 2005, Cancer research.
[20] Maria Merino,et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. , 2002, Cancer cell.
[21] A. Paetau,et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.
[22] H. Moch,et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. , 2001, Cancer research.
[23] Chun Xing Li,et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.
[24] B. Delahunt,et al. The Heidelberg classification of renal cell tumours , 1997, The Journal of pathology.
[25] S. Scherer,et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas , 1997, Nature Genetics.
[26] J. Gnarra,et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.